Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Conditions:   Bone Fracture;   Fresh Fracture Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Conditions:   Osteo Arthritis Knee;   Arthritis Interventions:   Device: Sustained Acoustic Device with 2.5% Diclofenac Patch;   Device: Sustained Acoustic Device with 0% Diclofenac Patch;   Drug: 2.5% Diclofenac Patches Sponsor:   ZetrOZ, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2023 Category: Research Source Type: clinical trials

Exercise vs. Topical Diclofenac vs. PRP
Condition:   Gonarthrosis Interventions:   Other: Exercise;   Other: Topical Diclofenac;   Other: Platelet-Rich-Plasma (PRP) Sponsor:   Istanbul University - Cerrahpasa (IUC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials